PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells is a research paper published in JCI Insight (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R21AR077769-02
Use of skin grafts programmed to express VEGF-C with biosensor feedback regulation to treat lymphedema
Stepping Strong Foundation
Grant: Innovator Award
National Institutes of Health
Grant: 1K08AR082031-01
Modifying adipocyte and pre-adipocyte cell fate in fibroadipose tissue of secondary lymphedema
NIDDK NIH HHS
Grant: P30 DK036836
NIAMS NIH HHS
Grant: R21 AR077769
NCI NIH HHS
Grant: P30 CA008748
NIAID NIH HHS
Grant: R01 AI155865
NIDDK NIH HHS
Grant: R01 DK082659
NIAMS NIH HHS
Grant: K08 AR082031
NIAID NIH HHS
Grant: R01 AI175379
Fields of Study
MeSH Terms
Keywords